Skip to content
← Full study record

NCT02793544 · OUTCOME

Subgroup Analysis of HIV-positive Subjects

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide · Source last updated 2025-08-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
365 days post transplant

What was measured

If CCR5delta32 homozygous donors are successfully found and used for one or more HIV-positive subjects, a descriptive analysis of baseline characteristics and outcomes for those HIV-positive subjects will be conducted, including the viral load detected over time obtained from collected samples.

Analysis population: Four subjects with HIV-positive, no statistical analysis for this outcome measure was completed due to limited HIV-positive rate. Descriptive analysis provided.

Groups in this outcome

Myeloablative Conditioning (MAC)

Participants received one of three regimens: cyclophosphamide and total body irradiation; busulfan and cyclophosphamide; or fludarabine and busulfan

Reduced Intensity Conditioning (RIC)

Participants received one of two regimens: fludarabine, cyclophosphamide, and low-dose total body irradiation

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Myeloablative Conditioning (MAC)0
Reduced Intensity Conditioning (RIC)4

Reported measurements

Source class 1

Survival Status: Alive

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Myeloablative Conditioning (MAC)0Not reportedNot reportedNot reportedNot reported
Reduced Intensity Conditioning (RIC)1Not reportedNot reportedNot reportedNot reported

Survival Status: Deceased (relapse)

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Myeloablative Conditioning (MAC)0Not reportedNot reportedNot reportedNot reported
Reduced Intensity Conditioning (RIC)2Not reportedNot reportedNot reportedNot reported

Survival Status: Deceased (fungal infection)

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Myeloablative Conditioning (MAC)0Not reportedNot reportedNot reportedNot reported
Reduced Intensity Conditioning (RIC)1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        1
      title
      Survival Status: Alive
    2. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        2
      title
      Survival Status: Deceased (relapse)
    3. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        1
      title
      Survival Status: Deceased (fungal infection)
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      4
    units
    Participants
description
If CCR5delta32 homozygous donors are successfully found and used for one or more HIV-positive subjects, a descriptive analysis of baseline characteristics and outcomes for those HIV-positive subjects will be conducted, including the viral load detected over time obtained from collected samples.
groups
  1. description
    Participants received one of three regimens: cyclophosphamide and total body irradiation; busulfan and cyclophosphamide; or fludarabine and busulfan
    id
    OG000
    title
    Myeloablative Conditioning (MAC)
  2. description
    Participants received one of two regimens: fludarabine, cyclophosphamide, and low-dose total body irradiation
    id
    OG001
    title
    Reduced Intensity Conditioning (RIC)
param Type
COUNT_OF_PARTICIPANTS
population Description
Four subjects with HIV-positive, no statistical analysis for this outcome measure was completed due to limited HIV-positive rate. Descriptive analysis provided.
reporting Status
POSTED
time Frame
365 days post transplant
title
Subgroup Analysis of HIV-positive Subjects
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice